![Joydeep Goswami](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joydeep Goswami
Direktor/Vorstandsmitglied bei
BIOLIFE SOLUTIONS, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Joydeep Goswami currently works at LGC Ltd., as President & Chief Executive Officer from 2025, BioLife Solutions, Inc., as Independent Director from 2021, TMune Therapeutics, Inc., as Director, OncoNano Medicine, Inc., as Director, and Life Technologies Japan Ltd., as President.
Dr. Goswami also formerly worked at Q Therapeutic Products, Inc., as Director, Q Therapeutics, Inc., as Director, Invitrogen Corp., as VP-Stem Cell & Regenerative Biology, McKinsey & Co., Inc., as Principal, Thermo Fisher Scientific, Inc., as President-Clinical Next Generation Sequencing from 2016 to 2019, Life Technologies Corp., as Vice President, and Illumina, Inc., as CFO, Chief Strategy & Development Officer from 2023 to 2024.
Dr. Goswami received his graduate degree, Masters Business Admin degree, and doctorate degree from Massachusetts Institute of Technology and undergraduate degree from Indian Institute of Technology Bombay.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOLIFE SOLUTIONS, INC. 0,11 % | 24.02.2026 | 53.156 ( 0,11 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Joydeep Goswami
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOLIFE SOLUTIONS, INC. | Direktor/Vorstandsmitglied | 01.10.2021 |
TMune Therapeutics, Inc.
 TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services | Direktor/Vorstandsmitglied | - |
Life Technologies Japan Ltd. | Präsident | - |
OncoNano Medicine, Inc.
 OncoNano Medicine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops proprietary nanotechnology platform for cancer therapeutics | Direktor/Vorstandsmitglied | - |
LGC Ltd.
 LGC Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences measurement and tools company | Vorstandsvorsitzender | 01.01.2025 |
Ehemalige bekannte Positionen von Joydeep Goswami
| Unternehmen | Position | Ende |
|---|---|---|
| ILLUMINA, INC. | Finanzdirektor/CFO | 15.04.2024 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01.09.2019 |
Q Therapeutic Products, Inc.
 Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel products to treat debilitating and fatal diseases | Direktor/Vorstandsmitglied | 08.03.2013 |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system | Direktor/Vorstandsmitglied | 08.03.2013 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Joydeep Goswami
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
BioLife Solutions, Inc.
 BioLife Solutions, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and markets proprietary and generic bio preservation media products for cells, tissues and organs | Health Technology |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
Illumina, Inc.
 Illumina, Inc. Medical SpecialtiesHealth Technology Operates as a biotechnology company that develops laboratory instruments | Health Technology |
Q Therapeutic Products, Inc.
Q Therapeutic Products, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel products to treat debilitating and fatal diseases | Commercial Services |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
LGC Ltd.
LGC Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a life sciences measurement and tools company | Commercial Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Life Technologies Japan Ltd. | |
Indian Institute of Technology Bombay
 Indian Institute of Technology Bombay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TMune Therapeutics, Inc.
TMune Therapeutics, Inc. BiotechnologyHealth Technology Provides cancer treatment research and technology development services | Health Technology |
OncoNano Medicine, Inc.
OncoNano Medicine, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops proprietary nanotechnology platform for cancer therapeutics | Health Technology |
